Haploidentical Transplantation (HAPLO) with Post-Transplant High-Dose Cyclophosphamide for Graft Vs Host Disease (GVHD) Prevention in the Treatment of High Risk Hematological Neoplasms

被引：0
|
作者：
Gayoso, Jorge [1 ]
Kwon, Mi
Serrano, David [1 ]
Balsalobre, Pascual [1 ]
Anguita, Javier
Pascual, Cristina
Perez-Corral, Ana
Buno, Ismael [2 ]
Martinez-Laperche, Carolina [1 ]
Castilla-Llorente, Cristina [3 ]
Heras, Inmaculada [3 ]
Jesus Pascual, Maria [4 ]
Caballero, Dolores [5 ]
Luis Diez-Martin, Jose
机构：
[1] Gregorio Maranon Gen Univ Hosp, Dept Hematol, Madrid, Spain
[2] Gregorio Maranon Hlth Res Inst IISGM, Madrid, Spain
[3] Hosp Gen Univ Morales Meseguer, Hematol & Clin Oncol Unit, Murcia, Spain
[4] Hosp Univ Carlos Haya, Malaga, Spain
[5] Hosp Univ Salamanca, Salamanca, Spain
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4545.4545
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4545
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease
    Al-Homsi, Ahmad Samer
    Roy, Tara S.
    Cole, Kelli
    Feng, Yuxin
    Duffner, Ulrich
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (04) : 604 - 611
  • [2] Haploidentical DLI for relapse post haplo bone marrow transplantation with high- dose of cyclophosphamide post-transplant as GvHD prophylaxis: is it feasible?
    Ghiso, A.
    Raiola, A. M.
    Gualandi, F.
    Dominietto, A.
    Varaldo, R.
    van Lint, M. T.
    Bregante, S.
    di Grazia, C.
    Lamparelli, T.
    Lucchetti, S.
    Geroldi, S.
    Bacigalupo, A.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S313 - S313
  • [3] Shortened Immunosuppression Following Peripheral Blood (PB) Haploidentical (haplo) Transplantation with Post-Transplant Cyclophosphamide (PTCy) Is Associated with Tolerable Rates of Graft-Vs-Host Disease (GVHD)
    DeZern, Amy E.
    Zahurak, Marianna
    Bolanos-Meade, Javier
    Jones, Richard J.
    [J]. BLOOD, 2019, 134
  • [4] Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies
    Esquirol, A.
    Pascual, M. J.
    Ortiz, M.
    Pinana, J. L.
    Ferra, C.
    Garcia Cadenas, I.
    Vilades, I.
    Brunet, S.
    Martino, R.
    Sierra, J.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 (09) : 1273 - 1279
  • [5] Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies
    A Esquirol
    M J Pascual
    M Ortiz
    J L Piñana
    C Ferra
    I Garcia Cadenas
    I Vilades
    S Brunet
    R Martino
    J Sierra
    [J]. Bone Marrow Transplantation, 2017, 52 : 1273 - 1279
  • [6] Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis
    Ghiso, Anna
    Raiola, Annamaria
    Gualandi, Francesca
    Dominietto, Alida
    Varaldo, Riccardo
    van Lint, Maria Teresa
    Bregante, Stefania
    Di Grazia, Carmen
    Lamparelli, Teresa
    Luchetti, Silvia
    Geroldi, Simona
    Tedone, Elisabetta
    Bacigalupo, Andrea P.
    [J]. BLOOD, 2012, 120 (21)
  • [7] Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML
    A Rashidi
    M Slade
    J F DiPersio
    P Westervelt
    R Vij
    R Romee
    [J]. Bone Marrow Transplantation, 2016, 51 : 1561 - 1564
  • [8] Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML
    Rashidi, A.
    Slade, M.
    DiPersio, J. F.
    Westervelt, P.
    Vij, R.
    Romee, R.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (12) : 1561 - 1564
  • [9] Using Haploidentical (haplo) Donors and High-Dose Post-Transplant Cyclophosphamide (PTCy) for Refractory Severe Aplastic Anemia (SAA)
    DeZern, Amy E.
    Dorr, Donna
    Luznik, Leo
    Bolanos-Meade, Javier
    Gamper, Christopher
    Symons, Heather J.
    Cooke, Kenneth R.
    Jones, Richard J., Sr.
    Brodsky, Robert A.
    [J]. BLOOD, 2015, 126 (23)
  • [10] Risk Factors for Graft-Versus-Host Disease (GVHD) in Haploidentical Hematopoietic Cell Transplantation (HCT) Using Post-Transplant Cyclophosphamide (PTCy)
    Rashidi, Armin
    Hamilton, Betty K.
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Alousi, Amin M.
    Jagasia, Madan
    Pidala, Joseph A.
    Arora, Mukta
    Im, Annie P.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345